Bajaj Life 2.0 completed: NBM rose from 11.1% to 24.5% over four quarters.
- Gst itc mitigation actions — answer hedged.
- Fy26 full year margin — answer hedged.
- Bajaj life 2h growth — answer hedged.
On how would you look to mitigate this volume impact?
Some actions we have already taken, quite successfully. A lot of this has been in terms of product structures and product mixes, and that is something we shall keep working on for the next 2 quarters. We are also in discussion with distribution on how to take this burden of GST. The tailwinds are sitting, and customers are seeing prices are down. So we are working with distribution and the sector together on how we can share this ITC burden with our distributors, our vendors, and how we can ourselves bury it down. We expect another 2 quarters for settling this entire process and taking all measures. By the end of that, we should be firmly placed.
From the full year point of view, will we have this delta of 500 to 700 basis points net of earnings, not factoring the GST negative impact? Or if I take an annualized impact of 450 basis points on the margin, is it fair to say that we will end up at a nineteen-teen margin for the full year?
We started this journey in second half of last year and March was the first full quarter that this entire change of Bajaj Life 2.0 became visible. Now March quarter was 4% margin expansion. June was 4.2%. This quarter, depending on whether you look gross or net of GST, we are upwards of 5.5%. Having run that for 3 quarters, it does give us confidence that the journey on margin expansion is on track. I would not want to hazard a guess whether it will be 4%, 6% or 7% margin expansion. But we are looking at significant consistent margin expansion. And absolute VNB rupee value is also growing. Probably 2 quarters we will have this noise or impact of GST. It's a transient impact. We do believe that over the next 2 quarters, we should be able to mitigate most of it. Had GST not been there, our confidence level in terms of margins would have definitely happened and we could have seen a margin expansion in the range of 4% to 6%.
On Bajaj Life growth - you will enter into a favorable base now in second half. Can we expect growth to come back in teens for you in second half or the disruptions with respect to GST, renegotiating commissions will have its bearing and growth for the full year can be still pretty muted?
The studied strategy that we had on a flattish 4 quarters is over, and that ended September,25. And here on, you should see a trajectory on growth. I would, at this point, not hazard a guess that it would be above the industry, but I wouldn't be surprised if it is. This is supported by the fact that the GST impact in terms of the tailwind that it's giving, will also be a significant part. We have already seen growth coming in the proprietary sales channel and the bancassurance side. Agency, some legs are still not steady, but bulk is under control. And we expect more will be visible in this coming quarter. Base effect notwithstanding, it will still be a favorably good quarter in terms of the top line.
On Bajaj General - in the Motor business, there seems to be a significant divergence between OD growth and TP growth. Will this divergence continue? And given the TP growth is very strong with low-price hike, is the loss ratio of around 59% in TP really sustainable? On Group Health PA and Retail Health growth being muted in first half - with 1/n accounting settling in second half, can we expect growth to grow back to nineteens to 20s in 2H?
Our philosophy is to maintain our market share in all lines of businesses and pick up good risk and serve the customer very well. On the TP question, if you look at our TP market share it had become lower than what our OD market share was. So we are trying to get that to where it should be. On the price hike of TP, for quite many years it did not happen, which means that our belief is that it should happen very soon. How soon - we can't tell because the government decides that. But because that has been overdue for quite some time, it should happen soon. On Group Health and PA - if the market does not give an opportunity to pick up risk at our price, which we feel is right, then we don't do that. When we see that opportunity, we do that. So whether in the next half, we will pick it up or not pick it up will all depend on the market and the pricing that we are comfortable with.
On protection - in the first half, growth is almost 70% YoY. Some sense on what is driving it. Do you think it is initial GST reduction and would come off after some time? Or is there something more to it?
In terms of growth, year-on-year is a difficult one because the base has already gone up. I think it's more to do with every channel basically picking it up significantly. On the GST impact, if any, the whole sector will still get the benefit of that for the future. We have been working on our underwriting analytics, profiling of customers, pre-profiling, democratizing it more in business channels, and I do see some headroom even more available there. The way we work our term strategy, like any other strategy is ground-up, segmented and not just one fit all. Our processes with AI at the back end and digitization has worked out quite well.
Closing thoughts on Bajaj Life trajectory.
When you look at the Life business, it is very long-term. If you look at the history of Bajaj Life over the last 7 to 8 years when we started the transformation, in 2018 without any external regulatory change or anything, we took a call to reduce ULIP from 72% by taking a big jump on to the traditional business. It did result in 1 year of lower growth because ticket sizes for traditional business were much lower. But the team executed very well. Last 3 years, we have seen several headwinds - first the tax on ULIP, then tax on traditional, the surrender charges and now the GST. Each of these really requires the company to review where it stands. We have started BALIC 2.0 with a very clear intention that we want to focus on consolidating the growth that we achieved in BALIC 1.0 with a greater focus on profitability. At least the results so far this year indicate that Bajaj Life is on the right track. The number of customers is growing. The percentage of customers who are going to be profitable and total mix are growing. We have cut out businesses which we believe will not give us a profit. There are other headwinds - for example, the yields coming off has taken a bit of a hit on the Non par Guaranteed business. Group protection is another area showing strong growth of 23%. Over the past two years, performance was volatile and patchy due to its dependence on bank and NBFC lending. However, it has now started picking up steadily. Our smaller banks, which we tied over the last few years are growing significantly well, which is also adding to margins.
On listing of Life Insurance and General Insurance business - any plans to list these companies separately, given that in the past there is regulatory push to list larger insurance companies. And in the last deal, your promoter group has taken a stake in these companies. Any plans to simplify the structure or list these companies in the medium term?
At the moment, our focus is on completing the acquisition. While we have changed the brand and effectively are in control now, the transaction is not complete yet. It will get done over the next few months, at least a substantial portion will get concluded. That is the first step. We are also with a new brand in place over the next 1 year. We have to be very watchful in both companies, in terms of retaining business and ensuring that we continue to grow and establish the Bajaj brand. After that we will review. I don't think in the next 2, 3 years we are seeing anything. We have other developments in the industry - IndAS coming up, RBC coming up, and IRDAI is making progress. For the next 2 to 3 years they will all play out. They have a big impact on the way numbers are reported, how the profitability is measured. We do have excess capital in both companies. In the case of Life we are consuming it for the right products and the right growth. In the case of non-life, we are generating capital. And we will review that at appropriate time by the Boards. But for the next 2 to 3 years because of all these external developments, we also have the insurance bill which may come up any time, which has the changes in the Insurance Act with 100% FDI, potentially composite licenses, ecosystems, many things. So all these have an impact on how you look at long-term strategy. Therefore, we will wait for all these to play out before we take a view.
Follow-up on loss ratio mitigation actions.
Let me explain the blip. In the beginning of the year, the OEMs increase their charges for our labor, spare parts. This happens in most of the years - you will see this blip initially happening. And then the company keeps on taking corrective actions and then it gets there. It will be a phenomenon that you will see in our business because our claims depend a lot on where it's getting service. If the OEMs increase their labor charges, it increases the spare part price, the claim ratio would move up immediately. If the hospital increases the charges, that would move up. But then how does the company react to it, and is able to bring it down while ensuring customer service is at the highest order is what the game is. Over decades we do this. So this is not a cause of worry.
How do you see the GST impact on Motor business loss ratios as well as in the Retail Health Insurance business?
GST has 2 components. One was input tax rate for distribution. Second was because of reduction of GST, you saw increase of car sales happen, where obviously the Motor business goes up. Also due to the Retail Health business, that also moves up. But at the same time hospitals and OEMs also have other benefits in spare parts and all. Now if they pass it on to customers, as was the expectation by the government, then that would also bring it down. But there, we have to see proof in terms of how much they really pass on to customers. So you will see increase in these lines of businesses, you would see the impact in losses, if they pass on the benefits they have in terms of spare part cost or in terms of medical equipment cost.
On health - we have almost infused more than INR 1,200 crores on the health side. We are seeing almost INR 30 crores quarterly run roughly losses. When do we see that part turning around? What would be our milestone benchmarks over the next 3 years for that business, in terms of profitability or something we can monitor quantitatively and qualitatively?
The way we look at the health businesses, our objective is to build a differentiated platform which takes care of the requirements of all stakeholders. The ecosystem has quite a few stakeholders - the consumer, insurers, providers or hospitals or doctors, which have slightly conflicting priorities. There is value creation possible - globally it's seen and hence it can be done. But our priority at this point of time is to create digital interface and put health data to use for users as well as payers or insurers and providers. Two things we are focused on as far as profit trajectory is concerned. One, how do we launch more services which balances requirements of all stakeholders? Second, how do we drive volume which will eventually lead to operating leverage. We are seeing operating leverage play out quarter-on-quarter, but it needs to steepen up - that will happen with more and more new services getting launched.
On BALIC itself - we are in the first year of a very significant leg up in our NBMs from closer to 10%, to 12% kind of range to now even excluding GST 17%, 18%, 19% kind of ranges. We had these targets of reaching around 20%. Will we stay in this band for some more time, consolidate and grow the scale and profitability both? Or do we think we will be looking at the further next journey from here on over the next 3 years, more moving in line with where the Tier 1 margins for players are?
We will take it a step at a time. There has been a leg up and I am happy that all of you are acknowledging the significant change. I would not jump ahead of my time and would not make too many forward-looking statements yet. We take it step by step. The entire sector is looking at the GST impact. We are working on it. The sector first has to gobble up that and then maybe talk of times beyond that. There is going to be another quarter when we will meet and another quarter after that as well. We will then be in a better position to respond to this.
On Bajaj Life - just wanted to understand the breakup of this 140-bps impact on the NBM margin, which is on account of the GST. So if you could help with the breakup between the renewal and the business done after 22nd September. And how do you look to mitigate the impact of GST ITC losses? Will you revise distributor commissions?
On H1 basis, the impact on NBM is 140 bps on account of GST. 50 bps of this impact is from the back book - that is for the business that was written from April,25 to 21st of September,25 because on the renewal commissions that we will pay in future, we will not get ITC credit. The rest 90 bps is for the business that was written from 22nd September to 30th September,25. The business mix that was issued from 22nd September to 30th September was skewed towards non-ULIP, because we had given an option to the customer that you could decide to have your policy issued immediately or wait for GST exemption to kick in. So the 90 bps is only reflected for that 9-day period, and has a skew towards non-ULIP mix. If we were to do nothing on ITC or the GST, the impact should be about 450 bps.
If I negate the 140 bps NBM impact, you almost reported closer to more than 16% margin for 1H FY '26 compared to 9.2% last year. You mentioned product mix, cost rationalization, and better product margins. If I break down this 7% delta improvement, how much was led by product mix, cost optimization, and better margin profile of products? Just to understand whether this is sustainable.
Let me pick up broadly the walk of the margin. We have mentioned in the past, the cost optimization that we were doing is giving us anything between 100 and 125 bps of margin expansion. If I had to give you a broad breakup on the mix, anything about 400 bps is coming out of the mix, rest is coming out of product repricing, and then there will be some compensating items, because our credit protection business continues to see intensive competitive pricing pressure where we are seeing some margin compressions. So broadly cost would be about 100 bps-125 bps, product mix would be about 400 bps. That's broadly 500-525 bps.
Follow-up on TP growth and higher acquisition cost - where is TP growth coming from?
If you look at our 2-wheeler new market share, few years back, it used to be 3% levels, we had moved it up to about 8% to 9% levels. For the quarter, it's hovering around 13.5% to 14% levels. Because we end up paying commissions upfront for 5 years, that's why the acquisition cost has moved up. This also leads to your point on TP growth being higher. As in 2-wheeler, the proportion of TP is much higher, that's why TP growth is also higher. So there are some segments which will deliver profits and hence the focus is there. While our endeavor is to grow TP market share where we were lagging, we will have to see how we manage the profitability on that front. On health - from the base now, the 1/n impact will get neutralized to some extent, so we should start seeing some benefit in the reported numbers. However, we have been reporting growth excluding 1/n. On Retail Health, while growth is looking muted, that's also because of long-term business. We reported muted growth of less than 1% for the quarter but if I exclude the impact of 1/n, the growth is actually 11% for the quarter. In fact, for the month of October, it's about 15%.
Congratulations on a very strong result in Bajaj Life - sharp increase in margins and GNP. My question is more related towards product mix. You have been able to change the product mix very successfully towards higher protection. On a QoQ basis, retail protection has grown very strongly, along with non-par and annuity. What is driving it? How sustainable is this growth in protection? Is there also a tailwind on GST? Has this continued in October? How would you see this in the second half - to judge what margins can be for FY '26 given the hit of ITCs?
We have been able to get the desired product mix - exactly what we told you a year back. More and more, we have seen that we still have significant room to move on the protection side. 33% of our customers are getting onboarded as protection customers. 17% of our customers in addition are getting added on some rider or the other. So 50% of the customer base has some element of protection. We did see an opportunity and innovation on the annuity side, which was vacant, and we were the first ones to make the move. On annuities, we were the first one with the deferred annuities a few years back. And now we will be moving on the short-term pay annuities, which has worked well, particularly in the 50 to 70 age band. High sum assured ULIPs account for about 8-10% of our overall product mix. There is more innovation in term as well, which we have done. This is already showing the good green shoots, and we consistently got the experiments working on term. As you work on Excel sheet - yes, we will be holding this product mix broadly in the medium term. No worries on this. Over cost optimization there is still room in that direction also. In the next 18 months, more and more of that happening.
Follow-up on retail protection sustainability and Bajaj Life 2.0 execution.
Two things here. If you look at the 70% outgrowth, I'll draw your attention to looking at this data for last 18 to 24 months. This retail protection growth has been largely consistent. It's not that it just came this quarter or this H1 - it's been consistent for last 18 to 24 months. Second, when we came in and talked about Bajaj Life 2.0 last year similar time, these were all conscious efforts thought through with set out actions that we had in our mind. As we were executing this, it was all about what we had planned for and how do we execute them. We have been pretty successful in executing what we had planned for. So we have said that in medium term, that's about 2 to 3 years, our term protection share should be 10% odd. And we are rightly headed in that direction.
On Bajaj General Insurance - in the past we have been operating at below 100% combined. But in the last couple of years, the combined ratio has been consistently above 100%. What are the reasons for that? And how do you see possibility of combined ratio below 100% over medium term?
If you look at the industry combined ratio, it has been over 115% between 115% and 120%. So Bajaj General has been beating the industry combined ratio by full 15 percentage points, and consistently for so many years. Even now when you see the delta in combined ratio, 1/n also pushes it up by at least a 1% point. Secondly, when you acquire businesses which have acquisition costs being paid upfront, the accounting puts it like that. If you look at the accounting system which is internationally followed, the combined would be much below 100%. When you are growing those lines of businesses, the expense moves up because you are paying it upfront. Broadly, ambition has been to be close to 100% at all points in time, which we are doing. This is one company which consistently for decades now has been outperforming industry by full 15% to 20% full points in combined ratio and still growing the customer base. We have issued the largest number of policies in the industry; nobody has been close to us. I would be very surprised to find more companies which can deliver these kinds of results consistently for such a long period of time.
Follow-up on ROE for Bajaj General.
What Sreeni is alluding to is that even if we assume a capital requirement of 200% for solvency (against the actual 150%), and Raman please correct me if I'm wrong, the ROE for Bajaj General (BAGIC) is currently over 20%. In fact, for the second quarter, we are delivering an ROE of around 24%. This demonstrates the kind of return on equity we are achieving, especially when the industry average ROE is just 3%. The outperformance of Bajaj General compared to the industry is by these significant margins.
Follow-up on combined ratio - long-term business written.
One more reason why this is happening - we are writing more and more of longer-term business. For example, on the 2-wheeler side, years back my market share was only 3%, this quarter it was 13%. And having to pay upfront for 5 years of commission, that causes new business strain in the life sense. That is one reason why the combined ratio is looking elevated. Similarly on 4-wheelers, our market share is now hovering above 9%, which used to be close to 7.5% three years back. So overall, our long-term businesses are much higher than the industry. That's why in the last few years you have seen this delta.
In the Motor business, motor OD loss ratios have increased to 71%, which is on the higher side versus the historical trend. Any trend reversal in this business, or just a quarterly blip?
It's just a quarterly blip. This will come down by the year-end is what we believe. With all the actions we are taking, we will come down to normal levels for full year is what I believe.
On Bajaj Life - within the Bajaj Group, a new star is getting born. We had 2 stars and now the third star also coming up. On the listing question - in light that now the profitability engine of Life Insurance is firmly in place, and at Bajaj Finserv level we may have requirements of capital, does it make sense to have a dividend policy and will that lead to some correction in the capital adequacy? Is there any thought process on that?
In perspective, the 2 insurance companies have been paying dividends since 2018, if I am not mistaken. Both of them have more or less paid back more than the capital that BFS and our ex-partner Allianz had invested in these businesses. So that was already on. As we go forward, this year obviously we could not take any dividends because we are in the midst of a change in shareholding. You cannot pay a dividend because that's not part of the arrangement with Allianz that we will share dividends with them. But once that is completed, we will review that. There are multiple things in relation - RBC, IndAS, composite licenses, and the surplus capital and the utilization. For Finserv itself, BFL is a dividend paying company. Bajaj General, Bajaj Life are paying dividends; currently our capital consumers are only our Health business and our AMC. Therefore, it is not significant capital that we need at the moment. We are quite comfortable at this stage. We will see once Allianz transaction is over what to do with that capital.
Anything quantitative benchmarks over a 3-year, 4-year period?
We watch 2 North Star metrics. One, how many health transactions are we processing - that is the most important North Star metric for us. Second, are we able to create use cases from those transactions insight. As far as quantitative financial output is concerned, we are very clear in next-to-next financial year, we should break even. So we will moderate our investment appropriately. That is FY'28.
On INR 120 crores GST impact in the quarter - is it going to be recurring for 2 quarters, is my understanding right? Or has all the impact been taken? Will there be an impact on embedded value or anything on the other side as we go ahead?
The INR 112 crore number is GST impact on PAT. There are 2 elements. Like I mentioned in case of NBM, there is impact of all the policies that were issued until 21st September, because as we keep paying commission on renewals, we would not get the GST credit. So out of INR 112 crores, INR 73 crores is back book - this is a one-time impact and is not going to recur. INR 39 crores is for the business that was written in the last 8, 9 days, and that is recurring. But I will make the same point - there was a significant product skew in those 8 days towards non-ULIP. So on an annualized basis, this impact will not be as proportionate. The number you are looking at is without taking any action. And as Tarun mentioned, it's been more than 2 months - close to 70 days since the GST changes were announced. We have already taken steps to mitigate the impact on PAT, VNB and margin. Coming to EV - there is an impact reported on EV. It comes to 44 bps of EV. Because our NAV is very high - because we have high net worth as a percentage of this, it is 102 bps. That will be more rightful measure to compare our back book impact on EV compared to anybody else.